Asahi Oligosynthesizer™

At Asahi Kasei Bioprocess, we bring over a decade of experience to every oligosynthesizer project that we undertake, continually improving our platform as we gain valuable feedback from sponsors and contract manufacturers alike.

This wealth of knowledge allows us to understand that oligonucleotides are a rather unique breed of therapeutic – chemically synthesized, yet much larger in size than classic small molecules. Hence, our engineers employ a hybrid approach when designing manufacturing-scale equipment for oligonucleotides, blending the best of antibody equipment and small molecule equipment design principles together to generate the ideal solution specifically for your oligonucleotide.